Name:	O
___	O
Unit	O
No:	O
___	O
Admission	O
Date:	O
___	O
Discharge	O
Date:	O
___	O
Date	O
of	O
Birth:	O
___	O
Sex:	O
F	O
Service:	O
MEDICINE	O
Allergies:	O
Penicillins	O
Attending:	O
___.	O
Chief	O
Complaint:	O
Jaundice	O
Major	O
Surgical	O
or	O
Invasive	O
Procedure:	O
EUS	O
ERCP	O
History	O
of	O
Present	O
Illness:	O
___	O
year	O
old	O
healthy	O
female	O
presented	O
with	O
fatigue	O
and	O
indigestion	O
and	O
was	O
found	O
to	O
have	O
abnormal	O
LFTs.	O
MRI/MRCP	O
shows	O
a	O
3	O
cm	O
mass	O
in	O
the	O
head	O
of	O
the	O
pancreas	O
causing	O
obstruction	O
of	O
the	O
CBD	O
and	O
PD.	O
TBili	O
11.1,	O
ALT	O
505,	O
AST	O
214,	O
AP	O
324.	O
.	O
Underwent	O
ERCP	O
and	O
found	O
strictures	O
in	O
the	O
CBD	O
and	O
PD	O
concerning	O
for	O
HOP	O
mass.	O
Brushed	O
the	O
CBD	O
and	O
left	O
a	O
plastic	O
stent	O
in	O
place.	O
She	O
had	O
some	O
mild	O
L	O
sided	O
chest	O
pain	O
post	O
procedure	O
which	O
resolved	O
with	O
0.5	O
mg	O
IV	O
dilaudid	O
in	O
the	O
ERCP	O
suite.	O
No	O
nausea.	O
Increased	O
blood	O
sugars	O
in	O
___	O
and	O
she	O
had	O
starting	O
dieting	O
and	O
exercise.	O
.	O
PAIN	O
SCALE:	O
___	O
REVIEW	O
OF	O
SYSTEMS:	O
CONSTITUTIONAL:	O
+7	O
lb	O
intentional	O
weight	O
loss.	O
No	O
fevers	O
or	O
chills.	O
HEENT:	O
[X]	O
All	O
normal	O
RESPIRATORY:	O
[X]	O
All	O
normal	O
CARDIAC:	O
[+]	O
L	O
sided	O
chest	O
pain	O
post	O
procedure	O
which	O
resolved	O
with	O
medications	O
GI:	O
[+]	O
early	O
satiey	O
but	O
no	O
n/v.	O
No	O
change	O
in	O
the	O
color	O
of	O
her	O
stool.	O
No	O
change	O
in	O
bowel	O
habits	O
GU:	O
[X]	O
All	O
normal	O
SKIN:	O
[+]	O
jaundice	O
over	O
the	O
past	O
few	O
days	O
MUSCULOSKELETAL:	O
[X]	O
All	O
normal	O
NEURO:	O
[X]	O
All	O
normal	O
ENDOCRINE:	O
[X]	O
All	O
normal	O
HEME/LYMPH:	O
[X]	O
All	O
normal	O
PSYCH:	O
[X]	O
All	O
normal	O
All	O
other	O
systems	O
negative	O
except	O
as	O
noted	O
above	O
Past	O
Medical	O
History:	O
H/o	O
asymptomatic	O
kidney	O
stone	O
H/o	O
cancerous	O
mole	O
on	O
posterior	O
R	O
knee	O
Social	O
History:	O
___	O
Family	O
History:	O
Her	O
mother	O
died	O
at	O
___	O
of	O
dementia	B-Dementia
and	O
PNA.	B-Lower_respiratory_tract_infection
She	O
had	O
localized	O
colon	O
cancer	O
in	O
her	O
___	O
which	O
was	O
treated	O
with	O
surgery.	O
Father	O
died	O
at	O
___	O
from	O
cancer	O
but	O
had	O
his	O
first	O
MI	O
at	O
___.	O
Her	O
mother	O
and	O
father	O
smoker.	O
Her	O
sister	O
died	O
of	O
an	O
MI	O
at	O
___	O
and	O
was	O
a	O
smoker.	O
Physical	O
Exam:	O
Admission	O
Exam:	O
Vitals:	O
97.6	O
PO	O
137	O
/	O
84	O
72	O
16	O
96	O
RA	O
CONS:	O
NAD,	O
comfortable	O
appearing	O
HEENT:	O
ncat,	O
+++	O
scleral	O
icterus	O
dry	O
MM	O
CV:	O
s1s2	O
rr	O
no	O
m/r/g	O
RESP:	O
b/l	O
ae	O
no	O
w/c/r	O
GI:	O
+bs,	O
soft,	O
NT,	O
ND,	O
no	O
guarding	O
or	O
rebound	O
MSK:no	O
c/c/e	O
2+pulses	O
SKIN:	O
no	O
rash	O
NEURO:	O
face	O
symmetric	O
speech	O
fluent,	O
Moving	O
all	O
extremities	O
appropriately.	O
Good	O
historian	O
PSYCH:	O
calm,	O
cooperative	O
LAD:	O
No	O
cervical	O
LAD	O
Discharge	O
Exam:	O
Vital	O
Signs:	O
98.2PO	O
140	O
/	O
77	O
76	O
18	O
96	O
RA	O
GEN:	O
Alert,	O
NAD	O
HEENT:	O
NC/AT,	O
+scleral	O
icterus	O
CV:	O
RRR,	O
no	O
m/r/g	O
PULM:	O
CTA	O
B	O
GI:	O
S/NT/ND,	O
BS	O
present	O
SKIN:	O
+	O
jaundice	O
NEURO:	O
Non-focal	O
Pertinent	O
Results:	O
Admission	O
Labs:	O
___	O
02:20PM	O
BLOOD	O
WBC-13.0*	O
RBC-4.40	O
Hgb-13.4	O
Hct-38.7	O
MCV-88	O
MCH-30.5	O
MCHC-34.6	O
RDW-15.2	O
RDWSD-49.1*	O
Plt	O
___	O
___	O
02:20PM	O
BLOOD	O
___	O
PTT-32.7	O
___	O
___	O
02:20PM	O
BLOOD	O
UreaN-33*	O
Creat-0.4	O
Na-130*	O
K-7.6*	O
Cl-95*	O
HCO3-22	O
AnGap-21*	O
___	O
02:20PM	O
BLOOD	O
ALT-490*	O
AST-257*	O
AlkPhos-451*	O
Amylase-19	O
TotBili-20.0*	O
___	O
11:30PM	O
BLOOD	O
Calcium-8.9	O
Phos-3.0	O
Mg-1.7	O
___	O
06:10AM	O
BLOOD	O
Lipase-63*	O
___	O
06:10AM	O
BLOOD	O
CEA-3.3	O
___	O
06:10AM	O
BLOOD	O
CA	O
___	O
-2806	O
Discharge	O
Labs:	O
___	O
06:10AM	O
BLOOD	O
WBC-10.9*	O
RBC-3.89*	O
Hgb-11.7	O
Hct-34.5	O
MCV-89	O
MCH-30.1	O
MCHC-33.9	O
RDW-14.6	O
RDWSD-46.9*	O
Plt	O
___	O
___	O
06:10AM	O
BLOOD	O
___	O
PTT-33.2	O
___	O
___	O
06:10AM	O
BLOOD	O
Glucose-160*	O
UreaN-25*	O
Creat-0.6	O
Na-134	O
K-4.0	O
Cl-99	O
HCO3-24	O
AnGap-15	O
___	O
06:10AM	O
BLOOD	O
ALT-336*	O
AST-99*	O
LD(LDH)-143	O
AlkPhos-381*	O
Amylase-123*	O
TotBili-7.4*	O
___	O
06:10AM	O
BLOOD	O
Albumin-3.5	O
Calcium-9.2	O
Phos-2.9	O
Mg-1.8	O
ERCP	O
Normal	O
major	O
papilla.	O
Cannulation	O
was	O
successful	O
using	O
a	O
sphincterotome	O
and	O
hands	O
free	O
technique.	O
An	O
irregular	O
2cm	O
stricture	O
was	O
noted	O
in	O
the	O
distal	O
CBD	O
was	O
upstream	O
dilation	O
to	O
12mm.	O
On	O
pancreatogram,	O
an	O
irregular	O
stricture	O
was	O
noted	O
as	O
the	O
duct	O
coursed	O
through	O
the	O
head	O
of	O
the	O
pancreas.	O
Given	O
stricture	O
in	O
both	O
ducts,	O
there	O
was	O
high	O
suspicion	O
for	O
malignancy	O
arising	O
in	O
the	O
head	O
of	O
the	O
pancreas.	O
A	O
limited	O
sphincterotomy	O
was	O
performed	O
in	O
the	O
12	O
o'clock	O
position	O
using	O
a	O
sphincterotome	O
over	O
an	O
existing	O
guidewire.	O
Cytology	O
samples	O
were	O
obtained	O
for	O
histology	O
using	O
a	O
brush	O
in	O
the	O
distal	O
CBD	O
(stricture).	O
A	O
7cm	O
by	O
___	O
___	O
biliary	O
stent	O
was	O
placed	O
successfully.	O
Pathology:	O
COMMON	O
BILE	O
DUCT	O
BRUSHINGS:	O
POSITIVE	O
FOR	O
MALIGNANT	O
CELLS	O
Consistent	O
with	O
adenocarcinoma	O
CT	O
Chest	O
-IMPRESSION:	O
1.	O
No	O
evidence	O
of	O
malignancy	O
in	O
the	O
chest.	O
2.	O
There	O
is	O
moderate	O
bibasilar	O
subsegmental	O
atelectasis.	O
CTA	O
Pancreas	O
-IMPRESSION:	O
1.	O
Hypodense	O
pancreatic	O
head	O
mass	O
measuring	O
2.5	O
x	O
2.6	O
cm	O
with	O
surrounding	O
fat	O
stranding	O
extending	O
into	O
the	O
duodenum,	O
though	O
the	O
fat	O
plane	O
between	O
the	O
mass	O
and	O
the	O
duodenum	O
is	O
preserved.	O
2.	O
Conventional	O
vascular	O
anatomy.	O
3.	O
No	O
vascular	O
involvement.	O
4.	O
Fluid	O
within	O
the	O
endometrial	O
cavity.	O
Further	O
evaluation	O
with	O
pelvic	O
ultrasound	O
is	O
recommended	O
given	O
patient's	O
age.	O
Brief	O
Hospital	O
Course:	O
___	O
y/o	O
F	O
with	O
no	O
significant	O
PMHx	O
other	O
than	O
recently	O
found	O
mass	O
in	O
the	O
HOP,	O
admitted	O
for	O
monitoring	O
following	O
EUS/ERCP.	O
Patient	O
underwent	O
ERCP	O
with	O
sphx,	O
brushings	O
for	O
cytology,	O
and	O
stent	O
placement.	O
She	O
tolerated	O
procedure	O
well,	O
and	O
diet	O
was	O
advanced	O
the	O
following	O
day.	O
Cytology	O
returned	O
positive	O
for	O
adenocarcinoma	O
after	O
discharge,	O
and	O
CA	O
___	O
returned	O
elevated	O
as	O
well.	O
The	O
patient	O
is	O
scheduled	O
to	O
f/u	O
in	O
pancreas	O
___	O
on	O
___	O
___.	O
Staging	O
CT	O
done	O
prior	O
to	O
discharge.	O
Of	O
note,	O
staging	O
CT	O
did	O
report	O
fluid	O
in	O
the	O
endometrial	O
cavity.	O
Pelvic	O
ultrasound	O
was	O
recommended	O
for	O
further	O
evaluation.	O
She	O
will	O
need	O
repeat	O
ERCP	O
in	O
6	O
weeks	O
for	O
stent	O
pull	O
and	O
consideration	O
of	O
metal	O
stent	O
insertion.	O
Statin	O
on	O
hold	O
given	O
elevated	O
LFTs.	O
Will	O
encourage	O
pt	O
to	O
further	O
discuss	O
this	O
with	O
her	O
PCP.	O
TRANSITIONAL	O
ISSUES:	O
-	O
f/u	O
in	O
pancreas	O
___	O
___	O
-	O
pt	O
will	O
need	O
non-urgent	O
pelvic	O
ultrasound	O
as	O
above	O
-	O
pt	O
will	O
need	O
repeat	O
ERCP	O
in	O
6	O
weeks	O
as	O
above	O
Medications	O
on	O
Admission:	O
The	O
Preadmission	O
Medication	O
list	O
is	O
accurate	O
and	O
complete.	O
1.	O
Simvastatin	O
10	O
mg	O
PO	O
QPM	O
2.	O
Vitamin	O
D	O
___	O
UNIT	O
PO	O
DAILY	O
3.	O
Fluticasone	O
Propionate	O
NASAL	O
2	O
SPRY	O
NU	O
DAILY	O
4.	O
potassium	O
citrate	O
10	O
mEq	O
(1,080	O
mg)	O
oral	O
DAILY	O
Discharge	O
Medications:	O
1.	O
Fluticasone	O
Propionate	O
NASAL	O
2	O
SPRY	O
NU	O
DAILY	O
2.	O
potassium	O
citrate	O
10	O
mEq	O
(1,080	O
mg)	O
oral	O
DAILY	O
3.	O
Vitamin	O
D	O
___	O
UNIT	O
PO	O
DAILY	O
Discharge	O
Disposition:	O
Home	O
Discharge	O
Diagnosis:	O
Bile	O
Duct	O
Obstruction	O
Pancreatic	O
Mass	O
Discharge	O
Condition:	O
Mental	O
Status:	O
Clear	B-Delirium
and	B-Delirium
coherent.	B-Delirium
Level	O
of	O
Consciousness:	O
Alert	O
and	O
interactive.	O
Activity	O
Status:	O
Ambulatory	B-Independently_mobile
-	B-Independently_mobile
Independent.	B-Independently_mobile
Discharge	O
Instructions:	O
You	O
presented	O
to	O
the	O
hospital	O
with	O
evidence	O
of	O
obstruction	O
of	O
your	O
bile	O
ducts	O
from	O
a	O
mass	O
in	O
your	O
pancreas.	O
You	O
had	O
a	O
procedure	O
called	O
an	O
ERCP	O
performed.	O
A	O
small	O
cut	O
was	O
made	O
in	O
your	O
bile	O
ducts.	O
You	O
had	O
a	O
stent	O
placed	O
and	O
you	O
had	O
samples	O
taken.	O
You	O
also	O
had	O
a	O
CAT	O
scan	O
to	O
further	O
evaluate	O
the	O
mass	O
in	O
your	O
pancreas.	O
It	O
is	O
very	O
important	O
that	O
you	O
keep	O
your	O
follow	O
up	O
appointment	O
in	O
the	O
pancreas	O
clinic	O
to	O
further	O
discuss	O
your	O
treatment	O
options.	O
Please	O
avoid	O
all	O
blood-thinning	O
agents	O
(aspirin,	O
Coumadin,	O
heparin,	O
ibuprofen	O
or	O
other	O
NSAIDs)	O
for	O
5	O
days.	O
It	O
was	O
a	O
pleasure	O
taking	O
part	O
in	O
your	O
medical	O
care.	O
Followup	O
Instructions:	O
___	O

